(Q34652136)

3 August 2017

1 reference

title

ACE inhibition and atherogenesis (English)

1 reference

3 August 2017

Bernward A Schölkens

1

1 reference

3 August 2017

Wolfgang Landgraf

series ordinal

2

1 reference

3 August 2017

publication date

1 April 2002

1 reference

Canadian Journal of Physiology and Pharmacology

3 August 2017

published in

1 reference

3 August 2017

volume

80

1 reference

3 August 2017

issue

4

1 reference

3 August 2017

page(s)

354-359

1 reference

Angiotensin converting enzyme inhibitor restrains inflammation-induced vascular injury in mice

3 August 2017

cites work

1 reference

Trandolapril inhibits atherosclerosis in the Watanabe heritable hyperlipidemic rabbit

21 January 2018

1 reference

Angiotensin I-converting enzyme in human circulating mononuclear cells: genetic polymorphism of expression in T-lymphocytes

21 January 2018

1 reference

Design of angiotensin converting enzyme inhibitors.

21 January 2018

1 reference

Increased accumulation of tissue ACE in human atherosclerotic coronary artery disease

21 January 2018

1 reference

The relevance of tissue angiotensin-converting enzyme: manifestations in mechanistic and endpoint data

21 January 2018

1 reference

Attenuation of atherosclerosis in apolipoprotein E-deficient mice by ramipril is dissociated from its antihypertensive effect and from potentiation of bradykinin

21 January 2018

1 reference

The Angiotensin-converting Enzyme Inhibition Post Revascularization Study (APRES)

21 January 2018

1 reference

Long-term ACE inhibition doubles lifespan of hypertensive rats

21 January 2018

1 reference

Late treatment with ramipril increases survival in old spontaneously hypertensive rats

21 January 2018

1 reference

Interactions among ACE, kinins and NO.

21 January 2018

1 reference

Effects of ramipril and vitamin E on atherosclerosis: the study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E (SECURE).

21 January 2018

1 reference

21 January 2018

1 reference

Ramiprilat prevents the development of acute coronary endothelial dysfunction in the dog.

21 January 2018

1 reference

Should an angiotensin-converting enzyme inhibitor be standard therapy for patients with atherosclerotic disease?

21 January 2018

1 reference

Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack

21 January 2018

1 reference

Atherosclerosis — An Inflammatory Disease

21 January 2018

1 reference

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

21 January 2018

1 reference

Ramiprilat enhances endothelial autacoid formation by inhibiting breakdown of endothelium-derived bradykinin

21 January 2018

1 reference

Endothelial protection by converting enzyme inhibitors

21 January 2018

1 reference

Clinical, public health, and research implications of the Heart Outcomes Prevention Evaluation (HOPE) Study

21 January 2018

1 reference

Enhanced expression of angiotensin-converting enzyme is associated with progression of coronary atherosclerosis in humans

21 January 2018

1 reference

Relative localization of angiotensin-converting enzyme, chymase and angiotensin II in human coronary atherosclerotic lesions

21 January 2018

1 reference

Inflammation influences vascular remodeling through AT2 receptor expression and signaling

21 January 2018

1 reference

History of the development of inhibitors of angiotensin I conversion

21 January 2018

1 reference

Angiotensin-converting enzyme expression in human carotid artery atherosclerosis

21 January 2018

1 reference

Angiotensin-converting enzyme inhibition prevents arterial nuclear factor-kappa B activation, monocyte chemoattractant protein-1 expression, and macrophage infiltration in a rabbit model of early accelerated atherosclerosis

21 January 2018

1 reference

Increased angiotensin-converting enzyme activity in coronary artery specimens from patients with acute coronary syndrome

21 January 2018

1 reference

Angiotensin II induces LOX-1, the human endothelial receptor for oxidized low-density lipoprotein

21 January 2018

1 reference

Evidence that macrophages in atherosclerotic lesions contain angiotensin II

21 January 2018

1 reference

Expression of angiotensin II and interleukin 6 in human coronary atherosclerotic plaques: potential implications for inflammation and plaque instability

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1139/Y02-038

1 reference

3 August 2017

1 reference